BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3496350)

  • 1. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency.
    Zerah M; Pang SY; New MI
    J Clin Endocrinol Metab; 1987 Aug; 65(2):227-32. PubMed ID: 3496350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay (ELISA) method for screening of non-classical steroid 21-hydroxylase deficiency.
    Ueshiba H; Zerah M; New MI
    Horm Metab Res; 1994 Jan; 26(1):43-5. PubMed ID: 8150423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study.
    Zerah M; Ueshiba H; Wood E; Speiser PW; Crawford C; McDonald T; Pareira J; Gruen D; New MI
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1662-7. PubMed ID: 2347899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Shibata Y
    Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
    Guechot J; Fiet J; Gourmelen M; Pham-Huu-Trung MT; Raux-Eurin MC; Brerault JL; Gueux B; Villette JM
    Ann Biol Clin (Paris); 1985; 43(4):333-7. PubMed ID: 4091295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. I. Microfilter paper methods for radioimmunoassay of 17 alpha-hydroxyprogesterone].
    Shimozawa K
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1845-9. PubMed ID: 6609091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-spot 17-hydroxyprogesterone in nonclassical 21-hydroxylase deficiency.
    Sólyom J
    Exp Clin Endocrinol; 1989; 94(3):295-9. PubMed ID: 2630309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
    Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
    J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 3. An enzyme-linked immunosorbent assay for dried blood 17 alpha-hydroxyprogesterone].
    Fukushi M; Arai O; Mizushima Y; Takasugi N; Fujieda K; Matsuura N
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):113-22. PubMed ID: 3494638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a highly sensitive nonisotopic immunoassay for the determination of salivary 17-hydroxyprogesterone: reference ranges throughout childhood and adolescence.
    Dressendorfer RA; Strasburger CJ; Bidlingmaier F; Klug I; Kistner A; Siebler T; Kiess W
    Pediatr Res; 1998 Nov; 44(5):650-5. PubMed ID: 9803445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency.
    Dewailly D; Vantyghem-Haudiquet MC; Sainsard C; Buvat J; Cappoen JP; Ardaens K; Racadot A; Lefebvre J; Fossati P
    J Clin Endocrinol Metab; 1986 Aug; 63(2):418-23. PubMed ID: 3013919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. II. A pilot neonatal mass-screening study in the west of Shizuoka Prefecture, Japan].
    Shimozawa K
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1860-73. PubMed ID: 6609092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of salivary 17-hydroxyprogesterone and its clinical usefulness in the study of hirsutism and the partial deficiency of 21-hydroxylase].
    Bonnín MR; Machuca I; Villabona C; González A; Soler J; Navarro MA
    Med Clin (Barc); 1994 Feb; 102(5):169-71. PubMed ID: 8127165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia].
    Fukushi M; Arai O; Mizushima Y; Takasugi N; Fujieda K; Matsuura N
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):683-96. PubMed ID: 3530828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Khandekar S; Lata V; Dash RJ
    Indian J Med Res; 1990 Apr; 92():79-82. PubMed ID: 2164496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.